Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD² initiative that are results of intra-Network collaborations

CTD²

January 28, 2021

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers

JCO Precision Oncology

CTD²

January 21, 2021

A modular master regulator landscape controls cancer transcriptional identity

Cell

CTD²

January 19, 2021

Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity

Cell Reports Medicine

CTD²

December 15, 2020

Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q

Cell Reports

CTD²

December 14, 2020

Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

Cancer Cell

CTD²

December 11, 2020

A meta-learning approach for genomic survival analysis

Nature Communications

CTD²

December 01, 2020

Progenitor identification and SARS-CoV-2 infection in human distal lung organoids

Nature

CTD²

November 30, 2020

N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB

iScience

CTD²

October 12, 2020

Functional precision medicine identifies new therapeutic candidates for medulloblastoma

Cancer Research

CTD²

October 05, 2020

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

The Journal of Clinical Investigation

Publications

Pages